Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DV Biomed CoROCO:6539 -1.19%63 Interest Coverage is 116.71 as of Jun. 2026, which is 68% above its 10-year median of 69.30. GuruFocus rates ROCO:6539 with a GF Score™ of 63/100 and a GF Value™ of NT$74.98 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 687 Drug Manufacturers companies, DV Biomed Co ranks worse than 55.31% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. DV Biomed Co's
Operating Income
for the
six
months ended in Jun. 2026 was NT$62.2 Mil. DV Biomed Co's Interest Expense for the
six
months ended in Jun. 2026 was NT$-0.5 Mil.
DV Biomed Co's interest coverage for the quarter that ended in Jun. 2026 was 116.71.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. DV Biomed Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for DV Biomed Co's Interest Coverage or its related term are showing as below:
ROCO:6539'
s Interest Coverage Range Over the Past 10 Years
Min: 9.93 Med: 69.3 Max: 8503.45
Current: 67.73
ROCO:6539's Interest Coverage is ranked worse than 55.31% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs ROCO:6539: 67.73
DV Biomed Co (ROCO:6539) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
DV Biomed Co Interest Coverage Related Terms
DV Biomed Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for DV Biomed Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, DV Biomed Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DV Biomed Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DV Biomed Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where DV Biomed Co's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DV Biomed Co (ROCO:6539) has a Interest Coverage of 116.71 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on DV Biomed Co and its competitors. This is 68% above median its historical median of 69.30. Over the past decade, DV Biomed Co's Interest Coverage has ranged from 9.93 to 8,503.45. According to the industry distribution chart, DV Biomed Co ranks #380 out of 687 companies in the Drug Manufacturers industry, placing it in the top 55.3%.
Is DV Biomed Co's Interest Coverage too high?
DV Biomed Co's current Interest Coverage of 116.71 is 68% above median its 10-year median of 69.30. Over the past 10 years, this metric has ranged from a low of 9.93 to a high of 8,503.45. The Drug Manufacturers industry median Interest Coverage is 12.75. DV Biomed Co's value of 116.71 is 815.4% above this industry median. Based on the distribution chart, DV Biomed Co ranks #380 out of 687 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DV Biomed Co has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DV Biomed Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DV Biomed Co ranks #380 out of 687 companies for Interest Coverage. This places DV Biomed Co in the lower half of its industry. The industry median Interest Coverage is 12.75. DV Biomed Co's value of 116.71 is 815.4% above this benchmark. Historically, DV Biomed Co's own Interest Coverage has ranged from 9.93 to 8,503.45 over the past decade. While the company's 10-year median is 69.30 vs. the industry median of 12.75, DV Biomed Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DV Biomed Co's current Interest Coverage of 116.71 is 815.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on DV Biomed Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DV Biomed Co's current Interest Coverage is 116.71, which is 68% above median its own 10-year median of 69.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DV Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, DV Biomed Co (ROCO:6539) is currently considered Possible Value Trap. The stock's GF Value™ is NT$74.98, compared to a current price of NT$41.50 — trading 44.7% below its estimated fair value. The current Interest Coverage is 116.71, which is 68% above median its 10-year median of 69.30 and 815.4% above the Drug Manufacturers industry median of 12.75. DV Biomed Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For DV Biomed Co (ROCO:6539), the current Interest Coverage is 116.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DV Biomed Co (ROCO:6539) Overvalued in 2026?
Based on GuruFocus' analysis, DV Biomed Co stock appears to be undervalued.
The current stock price of NT$41.50 is trading 44.7% below its estimated GF Value™ of NT$74.98.
GuruFocus considers DV Biomed Co to be Possible Value Trap.
Key valuation signals for ROCO:6539:
Interest Coverage: 116.71 (68% above median its 10-year median of 69.30)
GF Value™: NT$74.98 vs. price of NT$41.50 (44.7% below fair value)
Industry Position: 815.4% above the Drug Manufacturers median (#380 of 687)
No single metric tells the full story. See the ROCO:6539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DV Biomed Co Ltd provides medical supplies, skincare, and healthcare products. Its products include Perfectin and L'AMOUR Isis. The company also provides medical materials and needles (medicine), and healthcare products.
63GF Score
Get the complete analysis for ROCO:6539
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6539 has been successfully added to your 
